EBITDA Growth
Consolidated EBITDA of $137 million increased 10% from Q1 and 22% year-over-year, driven by stronger performance in the Packaging segment and improved pricing.
Packaging Segment Performance
Second quarter EBITDA for the Packaging segment increased by 9% sequentially to $119 million, with EBITDA margins improving by 1.3% to 15.6% in Q2.
Bear Island Facility Improvement
Production at Bear Island increased 8% to 82,000 tons versus the first quarter, with further improvements expected to reach 91% of the targeted ramp-up production level.
Debt Reduction
Net debt decreased by $112 million in the second quarter, with the leverage ratio going down to 3.8x from 4.2x at the end of the first quarter.
Tissue Business Growth
Second quarter sales in the Tissue segment increased 8% sequentially, driven by stronger volumes and favorable pricing and mix.
Liquidity Improvement
Available liquidity improved by $400 million since the end of Q1 to $595 million.